Cetuximab co-treatment with KRAS G12C inhibitors fulzerasib and sotorasib in human KRAS G12C non-small cell lung cancer cells. - Olmo-González D; Zhou M; Oliveira NG; Zhou F; Yan F; González J; València-Clua K; Molina-Vila MA; Bertrán-Alamillo J; Giménez-Capitán A; Codony-Servat J; Rosell R (Cell death discovery, 2026)